On February 15, 1978, the orientation of the interplanetary magnetic field (IMF) remained steadily northward for more than 12 hours. The ISEE 1 and 2 spacecraft were located near apogee on the dawnside flank of the magnetotail. IMP 8 was almost symmetrically located in the magnetosheath on the dusk flank and IMP 7 was upstream in the solar wind. Using plasma and magnetic field data, we show that (1) the magnetosheath flow speed on the flanks of the magnetotail steadily exceeded the solar wind speed by 20%, (2) surface waves of ∼5‐min period and very nonsinusoidal waveform were persistently present on the dawn magnetopause and waves of similar period were present in the dusk magnetosheath, and (3) the magnetotail ceased to flare at an antisunward distance of 15 RE. We propose that the acceleration of the magnetosheath flow is achieved by magnetic tension in the draped field configuration for northward IMF and that the reduction of tail flaring is consistent with a decreased amount of open magnetic flux and a larger standoff distance of the subsolar magnetopause. Results of a three‐dimensional magnetohydrodynamic simulation support this phenomenological model.

The hypothalamus may be involved in regulating homeostasis, motivation, and emotional behavior by controlling autonomic and endocrine activity. The hypothalamus communicates input from the thalamus to the pituitary gland, reticular activating substance, limbic system, and neocortex. This allows the output of pituitary hormones to respond to changes in autonomic nervous system activity. Environmental heat stress increases cutaneous blood flow and metabolism, and progressively decreases splanchnic blood flow. Severe heat exposure also decreases mean arterial pressure (MAP), increases intracranial pressure (ICP), and decreases cerebral perfusion pressure (CPP = MAP – ICP), all of which lead to cerebral ischemia and hypoxia. Compared with normothermic controls, rodents with heatstroke have higher hypothalamic values of cellular ischemia (e.g., glutamate and lactate-to-pyruvate ratio) and damage (e.g., glycerol) markers, pro-oxidant enzymes (e.g., lipid peroxidation and glutathione oxidation), proinflammatory cytokines (e.g., interleukin-1β and tumor necrosis factor-α), inducible nitric oxide synthase-dependent nitric oxide, and an indicator for the accumulation of polymorphonuclear leukocytes (e.g., myeloperoxidase activity), as well as neuronal damage (e.g., apoptosis, necrosis, and autophagy) after heatstroke. Hypothalamic values of antioxidant defenses (e.g., glutathione peroxidase and glutathione reductase), however, are lower. The ischemic, hypoxic, and oxidative damage to the hypothalamus during heatstroke may cause multiple organ dysfunction or failure through hypothalamic-pituitary-adrenal axis mechanisms. Finding the link between the signaling and heatstroke-induced hypothalamic oxidative and ischemic damage might allow us to clinically attenuate heatstroke. In particular, free radical scavengers, heat shock protein-70 inducers, hypervolemic hemodilution, inducible nitric oxide synthase inhibitors, progenitor stem cells, flutamide, estrogen, interleukin-1 receptor antagonists, glucocorticoid, activated protein C, and baicalin mitigate preclinical heatstroke levels.

TWINS is the first mission to perform stereo imaging of the Earth's ring current. The magnetic storm on 22 July 2009 was at the time the largest storm observed since TWINS began routine stereo imaging in June 2008. On 22 July 2009, the Dst dropped to nearly −80 nT at 0700 and 1000 UT. During the main phase, and at the peak of the storm, TWINS 1 and 2 were near apogee and moving between predawn and postdawn local time. The energetic neutral atom (ENA) imagers on the two spacecraft captured the storm intensification and the formation of the partial ring current. The peak of the high‐altitude ENA emissions was seen in the midnight‐to‐dawn local time sector. The development of this storm has been simulated using the comprehensive ring current model (CRCM) to understand and interpret the observed signatures. We perform CRCM runs with constant and time‐varying magnetic field. The model calculations are validated by comparing the simulated ENA and ion flux intensities with TWINS ENA images and in situ ion data from a THEMIS satellite. Simulation with a static magnetic field produces a strong shielding electric field that skews the ion drift trajectories toward dawn. The model's corresponding peak ENA emissions are always more eastward than those in the observed TWINS images. On the other hand, the simulation with a dynamic magnetic field gives better spatial agreement with both ENA and in situ particle data, suggesting that temporal variations of the geomagnetic field exert a significant influence upon global ring current ion dynamics.

No abstract

Abstract. The aim of the present study was to ascertain whether aminoguanidine attenuated intracranial hypertension and cerebral ischemic injury in experimental heatstroke. Urethaneanesthetized rats were exposed to heat stress (ambient temperature of 43°C) to induce heatstroke. Control rats were exposed to 24°C. Mean arterial pressure, cerebral perfusion pressure, and cerebral blood flow after the onset of heatstroke were all significantly lower than in control rats. However, colonic temperature, intracranial pressure, heart rate, cerebral inducible nitric oxide synthase (iNOS)-dependent NO, and neuronal damage score were greater after the onset of heatstroke. Aminoguanidine (30 mmol / kg, i.v.; 30 min before the start of heat exposure) pretreatment significantly attenuated the heatstroke-induced hyperthermia, arterial hypotension, intracranial hypertension, cerebral ischemia and neuronal damage, and increased iNOS-dependent NO formation in the brain. The extracellular concentrations of ischemic (e.g., glutamate and lactate / pyruvate ratio) and damage (e.g., glycerol) markers in the hypothalamus were also increased after the onset of heatstroke. Aminoguanidine pretreatment significantly attenuated the increase in hypothalamic ischemia and damage markers associated with heatstroke. Delaying onset of aminoguanidine administration (i.e., 0 or 30 min after the start of heat exposure) reduced the preventive efficiency on heatstroke-induced hyperthermia, arterial hypotension, intracranial hypertension, cerebral ischemia, and increased iNOS-dependent NO formation in brain. These results suggest that aminoguanidine protects against heatstroke-induced intracranial hypertension and cerebral ischemic injury by inhibition of cerebral iNOS-dependent NO production.